These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 32302025

  • 1. TEG improves anticoagulation management during cardiopulmonary bypass complicated by antiphospholipid syndrome.
    Nakajima T, Kato H, Mathis BJ, Hiramatsu Y, Sakamoto H.
    J Card Surg; 2020 Jun; 35(6):1354-1356. PubMed ID: 32302025
    [Abstract] [Full Text] [Related]

  • 2. Anticoagulation management during cardiopulmonary bypass in patients with antiphospholipid syndrome.
    Seki T, Shingu Y, Sugiki H, Wakasa S, Katoh H, Ooka T, Tachibana T, Kubota S, Matsui Y.
    J Artif Organs; 2018 Sep; 21(3):363-366. PubMed ID: 29541945
    [Abstract] [Full Text] [Related]

  • 3. Perioperative anticoagulation management during aortic valve replacement complicated by antiphospholipid syndrome.
    Nakajima T, Enomoto Y, Ishigaki M, Hasegawa Y, Tokunaga C, Hiramatsu Y, Sakamoto H.
    J Card Surg; 2017 Oct; 32(10):633-635. PubMed ID: 28944492
    [Abstract] [Full Text] [Related]

  • 4. Validation of viscoelastic coagulation tests during cardiopulmonary bypass.
    Ortmann E, Rubino A, Altemimi B, Collier T, Besser MW, Klein AA.
    J Thromb Haemost; 2015 Jul; 13(7):1207-16. PubMed ID: 25903995
    [Abstract] [Full Text] [Related]

  • 5. Strategies for managing heparin therapy in patients with antiphospholipid antibody syndrome.
    Mehta TP, Smythe MA, Mattson JC.
    Pharmacotherapy; 2011 Dec; 31(12):1221-31. PubMed ID: 22122183
    [Abstract] [Full Text] [Related]

  • 6. Management of a Patient With Antiphospholipid Syndrome Undergoing Aortic Valve Replacement Using the Hepcon Hemostasis Management System Plus and Rotational Thromboelastometry: A Case Report.
    Samejima Y, Kodaka M, Ichikawa J, Mori T, Ando K, Nishiyama K, Komori M.
    A A Case Rep; 2017 Mar 01; 8(5):100-104. PubMed ID: 28098662
    [Abstract] [Full Text] [Related]

  • 7. Severe antiphospholipid syndrome and cardiac surgery: Perioperative management.
    Mishra PK, Khazi FM, Yiu P, Billing JS.
    Asian Cardiovasc Thorac Ann; 2016 Jun 01; 24(5):473-6. PubMed ID: 25829458
    [Abstract] [Full Text] [Related]

  • 8. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
    Levin AI, Heine AM, Coetzee JF, Coetzee A.
    J Cardiothorac Vasc Anesth; 2014 Apr 01; 28(2):224-9. PubMed ID: 24461364
    [Abstract] [Full Text] [Related]

  • 9. A novel thrombelastograph tissue factor/kaolin assay of activated clotting times for monitoring heparin anticoagulation during cardiopulmonary bypass.
    Chavez JJ, Foley DE, Snider CC, Howell JC, Cohen E, Muenchen RA, Carroll RC.
    Anesth Analg; 2004 Nov 01; 99(5):1290-1294. PubMed ID: 15502019
    [Abstract] [Full Text] [Related]

  • 10. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB, Veerhoek D, van den Brom CE, van Barneveld LJ, Boer C.
    J Cardiothorac Vasc Anesth; 2014 Apr 01; 28(2):235-41. PubMed ID: 24342152
    [Abstract] [Full Text] [Related]

  • 11. Heparin detection by the activated coagulation time: a comparison of the sensitivity of coagulation tests and heparin assays.
    Murray DJ, Brosnahan WJ, Pennell B, Kapalanski D, Weiler JM, Olson J.
    J Cardiothorac Vasc Anesth; 1997 Feb 01; 11(1):24-8. PubMed ID: 9058215
    [Abstract] [Full Text] [Related]

  • 12. Thromboelastography is a suboptimal test for determination of the underlying cause of bleeding associated with cardiopulmonary bypass and may not predict a hypercoagulable state.
    Welsh KJ, Padilla A, Dasgupta A, Nguyen AN, Wahed A.
    Am J Clin Pathol; 2014 Oct 01; 142(4):492-7. PubMed ID: 25239416
    [Abstract] [Full Text] [Related]

  • 13. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD, Buell R, Nzewi OC, McClelland DB, Mankad PS.
    J Cardiothorac Vasc Anesth; 2008 Feb 01; 22(1):47-52. PubMed ID: 18249330
    [Abstract] [Full Text] [Related]

  • 14. Anticoagulation Management and Heparin Resistance During Cardiopulmonary Bypass: A Survey of Society of Cardiovascular Anesthesiologists Members.
    Sniecinski RM, Bennett-Guerrero E, Shore-Lesserson L.
    Anesth Analg; 2019 Aug 01; 129(2):e41-e44. PubMed ID: 30540616
    [Abstract] [Full Text] [Related]

  • 15. Evidence based coagulation monitors: heparin monitoring, thromboelastography, and platelet function.
    Shore-Lesserson L.
    Semin Cardiothorac Vasc Anesth; 2005 Mar 01; 9(1):41-52. PubMed ID: 15735843
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay.
    Tuman KJ, McCarthy RJ, Djuric M, Rizzo V, Ivankovich AD.
    J Cardiothorac Vasc Anesth; 1994 Apr 01; 8(2):144-9. PubMed ID: 8204806
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of the Hepcon system in reducing hemorrhagic and thrombotic complications in antiphospholipid syndrome patients undergoing cardiac surgery.
    Michael S, Sofia MG, Wei W, Patrick G, John A, Dana A.
    Perfusion; 2024 Oct 01; 39(7):1424-1430. PubMed ID: 37608561
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.